T2D Research

Russian Ancestry Groups: Phenotype, Blood, Immunity, and Disease Differences

Properties2
tagssynthesis, ancestry, epidemiology, immunology, genetics
aliasesBlood, Immunity, and Disease Differences

11 min read

TL;DR Comparison

T2D-related differences are colelcted at Russian Ancestry Groups: Type 2 Diabetes Differences.

Group or contrastPhenotype / anthropometryBlood or metabolic markersGenetic markersImmunity-related evidenceGeneral disease pattern signalEvidence strength
Chechens / North Caucasus peoplesMarkelova et al. found Chechens had the highest BMI, waist circumference, hip circumference, systolic BP, and diastolic BP among Chechens, Tatars, and Yakuts.1 Kononenko et al. similarly reported higher BMI in North Caucasus peoples than Volga peoples.2Higher cardiometabolic anthropometrics in Markelova et al.1No Chechen-specific non-disease genetic-marker set is established; Chechens mainly serve as a western-Eurasian-like contrast in the Markelova ancestry framework.1Direct baseline immune phenotyping is sparse in the sources.Not yet well summarized.Moderate for anthropometry; weak for direct baseline immunity and non-disease genetic markers.12
Tatars / Volga peoplesMarkelova et al. found Tatars had lower WHR, waist circumference, and diastolic BP than Chechens and Yakuts.1Non-disease-specific blood/metabolic evidence is limited.Suvorova et al. 2026 reports several medically actionable variants enriched in self-identified Tatars/Bashkirs, including variants in LDLR, BRCA1, BRCA2, SCN5A, MSH6, and RYR1.3Direct baseline immune phenotyping is sparse.Not yet well summarized.Moderate for anthropometry and rare-variant context; weak for direct baseline immunity.13
Yakuts / SakhaMarkelova et al. found highest WHR in Yakuts despite BMI similar to Tatars; Yakut rural studies report nutrition-transition risk.14Markelova et al. found highest triglycerides and HDL and lowest atherogenic index in Yakuts.1Yakut blood-group/serum-protein studies report population-specific AB0, Rh, HP, TF, GC, PI, and complement C3 frequencies; these are genetic/serological markers, not direct immune-cell function.5 Sakha/Yakut studies also place Yakuts closer to Siberian/East Asian-related ancestry than western Russian groups.67Direct Yakut functional immune evidence is sparse.5Not yet well summarized here.Moderate for metabolic traits and blood-marker genetics; weak for direct functional immunity.15
Broader Russian ancestry structureMarkelova and Genome Russia studies show strong separation between western Russian/European-like and Yakut/East-Asian/Siberian-like ancestry components.17Broad Russian ancestry studies do not provide a single blood/metabolic phenotype; blood/metabolic interpretation should stay group- and cohort-specific.12Genome Russia reported Yakut divergence from western Russian populations in medically relevant, infectious-disease, selection, and pharmacogenomic allele sets.7 Suvorova et al. adds large-scale urban WGS evidence that clinically actionable variant frequencies differ across self-identified Russian population groups.3General immunogenomic literature shows genetic ancestry and population context are associated with immune-cell composition and stimulated immune responses, but Russian-specific PBMC data remain limited.89Disease risk should be interpreted as ancestry plus geography, diet, urbanization, socioeconomic context, ascertainment, and variant-interpretation resources; T2D/MetS details belong in Russian Ancestry Groups: Type 2 Diabetes Differences. 283Strong for genetic structure and rare-variant frequency differences; indirect for immune/disease mechanisms.1738

Bottom Line

The clearest Russian-population evidence is not yet PBMC immune phenotyping; it is anthropometric, metabolic, genetic, and epidemiological.123 Chechens/North Caucasus peoples show higher BMI and body-size measures but lower detected carbohydrate-metabolism disorder prevalence; Tatars/Volga peoples show higher carbohydrate-metabolism disorder prevalence, several inflammation-linked MetS/T2D genetic associations, and NGI evidence for some enriched medically actionable variants in Tatars/Bashkirs; Yakuts show an East-Asian/Siberian-like genetic background, distinctive lipid/WHR patterns, historically low fasting glucose in rural samples, and blood/serum marker differences.1210114563 Direct claims about ancestry-specific immune cell composition in these Russian populations should remain hypotheses unless tested in the project data.8

Evidence By Domain

Anthropometric and Clinical Differences

Markelova et al. 2025 directly compared Chechen, Tatar, and Yakut participants and adjusted ancestry associations for T2D status, age, and sex.1 In that cohort, Chechens had the highest BMI, waist circumference, hip circumference, systolic blood pressure, and diastolic blood pressure; Yakuts had the highest waist-hip ratio; and Tatars had the lowest WHR, waist circumference, and diastolic BP among the three groups.1 The paper also reported Yakuts had the highest triglycerides and HDL and the lowest atherogenic index of plasma.1

Kononenko et al. 2022 analyzed the NATION study by broad Russian ethnic categories.2 It found that carbohydrate-metabolism disorders were most frequent in the “Peoples of the Volga region” group (31.2%) and least frequent in “Peoples of the North Caucasus” (15.6%).2 It also reported that BMI in Volga peoples was significantly lower than in North Caucasus peoples, consistent with Markelova et al.’s observation that Chechens can have high BMI while not showing the highest carbohydrate-metabolism disorder burden.21

Yakut / Sakha Metabolic Features

Snodgrass et al. 2010 studied 166 rural Yakut adults in Tyungyulyu, Sakha Republic.4 Metabolic syndrome was uncommon (10% overall), elevated fasting glucose and high triglycerides were uncommon, mean fasting glucose was low in both women and men, and no participant was classified as diabetic.4 The authors warned that obesity and market-food transition could increase future MetS and impaired fasting glucose.4

More recent Yakutia literature points toward that transition.1213 A 2025 rural Central Yakutia study reported metabolic syndrome prevalence of 28.1% and associations with obesity, abdominal obesity, hypertension, smoking, age, education, and occupation.12 A study of indigenous minorities of northern Yakutia also reported high abdominal obesity, hypertension, and metabolic syndrome, especially among women.13 These sources are not directly Chechen/Tatar/Yakut comparative, but they show that Yakut/Siberian metabolic profiles are dynamic and strongly environment-dependent.412

Blood and Serum Marker Differences

Yakut blood-related evidence is largely from classic population genetics and serological marker studies.5 Tarskaia et al. reported polymorphism in AB0 and Rh blood groups and serum proteins HP, TF, GC, PI, and complement C3 in Yakut populations, with gene-frequency ranges varying across Yakut subpopulations.5 These data show population-specific blood/serum marker structure but do not measure PBMC cell states, cytokine production, or disease activity.5

Sakha/Yakut genetic structure studies show that Yakuts cluster with Siberian/East Asian-related populations rather than western Russian populations.67 Autosomal and uniparental analyses of Sakha native populations connect Yakut ancestry to South Siberian and East Asian lineages, with some West Eurasian admixture.6 Genome Russia sequencing similarly found Yakuts separate from Pskov/Novgorod western Russian populations and reported differences in medically relevant, infectious-disease, natural-selection, and pharmacogenomic allele sets.7 These are useful context for ancestry-aware study design, but they are not direct phenotype measurements and do not by themselves establish disease-relevant immune mechanisms.67

Large-Scale Russian WGS Secondary-Finding Evidence

Suvorova et al. 2026 analyzed 42,826 unrelated, generally healthy adult participants from the National Genetic Initiative and found ACMG SF v3.2 secondary findings in 2.76% of participants.3 Cancer-associated findings were most frequent, followed by cardiovascular findings; the highest-count genes included BRCA1, BRCA2, RYR1, and LDLR.3

The study is useful here because it shows that Russian population genetic structure affects rare clinically actionable variant frequencies. Several variants were enriched in self-identified Tatars and Bashkirs, including LDLR, BRCA1, BRCA2, SCN5A, MSH6, and RYR1 variants, while a BRCA2 variant and a candidate BRCA2 pLOF variant were concentrated among self-identified Udmurts.3 This supports the need for Russian-population-aware variant interpretation, but it should not be treated as PBMC immune evidence or as T2D-specific evidence.3

Immunity and Inflammation Evidence

Direct Russian multi-ancestry immune phenotyping is sparse.8 The strongest population-specific immune/metabolic evidence found in this search is from Tatar candidate-gene studies:1011

  • Kochetova et al. 2022 studied 271 Tatar MetS patients and 327 healthy Tatars in Bashkortostan.10 TNFRSF1B rs1061624 was associated with MetS and TNF-alpha levels; TNFA rs1800629 was associated with TNF-alpha and albuminuria; CRP variants/haplotypes were associated with hsCRP, insulin resistance, HbA1c, fasting/postprandial insulin, BMI, WHR, and lipid traits.10
  • Kochetova et al. 2019 studied 440 Tatar T2D patients and 500 Tatar controls.11 CCL20 rs6749704 and CCL5 rs2107538 were associated with T2D; CCL11 rs1696941 was associated with T2D onset age, duration, and HbA1c; CCL17 and CCL20 variants were associated with obesity or glycemic traits.11

These studies support a Tatar inflammation/chemokine-metabolic disease axis, but they are candidate-gene association studies in selected cohorts.1011 They should not be interpreted as showing that Tatars have a particular PBMC immune state at baseline relative to Chechens or Yakuts.8

General immunogenomic literature supports the plausibility that genetic ancestry and population context are associated with immune traits.89 Reviews and single-cell studies show population differences in immune-cell composition, cytokine levels, and stimulated immune responses, with both genetics and environment contributing.89 However, those studies are mostly African/European/East Asian comparisons, not Russian minority-population comparisons.9 For the current paper, they support the rationale for testing ancestry effects in PBMCs but not a direct claim about Chechen/Tatar/Yakut immune differences.8

Interpretation For The PBMC Ancestry Paper

  • Treat Chechen, Tatar, and Yakut labels as population/ancestry strata that carry genetic, geographic, environmental, dietary, and healthcare-access information.12
  • Use Markelova et al. as the direct same-cohort anchor for Chechen/Tatar/Yakut phenotypic and genetic differences.1
  • Use Kononenko et al. as broad epidemiological support that Russian ethnic groups differ in carbohydrate-metabolism disorder prevalence and risk-factor profiles.2
  • Use Tatar inflammation-gene studies as pathway-level plausibility for CRP/TNF/chemokine involvement in metabolic disease, not as direct PBMC ancestry evidence.1011
  • Use Yakut blood/serum marker and Sakha genetic-structure studies as ancestry-context evidence, not as proof of disease-relevant immune-cell differences.56
  • Use Suvorova et al. 2026 as large-scale Russian rare-variant context, especially for self-reported population-group differences in medically actionable variants, not as T2D or PBMC evidence.3

Evidence Gaps

  • Few studies directly compare Chechens, Tatars, and Yakuts for immune-cell composition, cytokine levels, or PBMC transcriptomic states.8
  • Most Russian immune/metabolic candidate-gene work is population-specific rather than multi-population comparative.1011
  • Environmental confounding is substantial: diet, urbanization, climate, physical activity, socioeconomic status, medication, and recruitment site can plausibly explain part of the observed differences.28
  • Large-scale Russian WGS data currently support rare-variant frequency differences across self-identified groups, but genotype-inferred ancestry and functional validation are still needed for founder-effect claims and candidate pLOF interpretation.3
  • Published evidence does not yet identify which PBMC features differ by Russian ancestry group; this remains a project-data question.8

Sources Consulted

  • Markelova, E. E., et al. (2025). Genetic and phenotypic heterogeneity of type 2 diabetes across Russian ancestry groups. Frontiers in Endocrinology, 16, 1672403. https://doi.org/10.3389/fendo.2025.1672403
  • Kononenko, I. V., Shestakova, M. V., Elfimova, A. R., Khomyakova, I. A., Buzhilova, A. P., & Mokrysheva, N. G. (2022). Ethnic differences in risk factors and prevalence of type 2 diabetes in the adult population of the Russian Federation. Diabetes Mellitus, 25(5), 418-438. https://doi.org/10.14341/DM12935
  • Snodgrass, J. J., et al. (2010). Impaired fasting glucose and the metabolic syndrome in an indigenous Siberian population. International Journal of Circumpolar Health, 69(1), 87-98. https://doi.org/10.3402/ijch.v69i1.17430
  • Kochetova, O. V., Avzaletdinova, D. S., & Korytina, G. F. (2022). Association of inflammation gene polymorphism with increased risk of metabolic syndrome in Tatar ethnic group. Russian Open Medical Journal, 11, e0305. https://doi.org/10.15275/rusomj.2022.0305
  • Kochetova, O. V., Avzaletdinova, D. S., Morugova, T. V., & Mustafina, O. E. (2019). Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia. Molecular Biology Reports, 46, 887-896. https://doi.org/10.1007/s11033-018-4544-6
  • Tarskaia, L. A., Bychkovskaia, L. S., Pai, G. V., et al. (2002). Distribution of the AB0 blood groups and the HP, TF, GC, PI and C3 serum proteins in Yakuts. Russian Journal of Genetics, 38, 548-553. https://doi.org/10.1023/A:1015547432044
  • Fedorova, S. A., et al. (2013). Autosomal and uniparental portraits of the native populations of Sakha (Yakutia): implications for the peopling of Northeast Eurasia. BMC Evolutionary Biology, 13, 127. https://pmc.ncbi.nlm.nih.gov/articles/PMC3695835/
  • Zhernakova, D. V., et al. Genome-wide sequence analyses of ethnic populations across Russia. Genome Russia / related full-text PDF surfaced via web search. https://www.medgenetics.ru/UserFile/File/Doc/Publik_BAZA%20NIIMG/2019/Zhernakova-Genomics-2019.pdf
  • Suvorova, Y., Monakhova, A., Chekanov, N., et al. (2026). Carrier frequencies of medically actionable pathogenic variants in the Russian population. International Journal of Molecular Sciences, 27, 5344. https://doi.org/10.3390/ijms27125344

Reusable Footnotes

Footnotes

  1. Markelova et al. 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12457129/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20

  2. Kononenko et al. 2022, https://www.dia-endojournals.ru/jour/article/view/12935/0?locale=en_US ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12

  3. Suvorova et al. 2026, https://doi.org/10.3390/ijms27125344 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13

  4. Snodgrass et al. 2010, https://pubmed.ncbi.nlm.nih.gov/20167159/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  5. Tarskaia et al. 2002, https://link.springer.com/article/10.1023/A:1015547432044 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  6. Fedorova et al. 2013, https://pmc.ncbi.nlm.nih.gov/articles/PMC3695835/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  7. Genome Russia / Zhernakova et al. full-text PDF surfaced by search, https://www.medgenetics.ru/UserFile/File/Doc/Publik_BAZA%20NIIMG/2019/Zhernakova-Genomics-2019.pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  8. Human immune diversity review, https://www.nature.com/articles/s41590-021-01058-1 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12

  9. Single-cell PBMC ancestry-response study, https://www.nature.com/articles/s41586-023-06422-9 ↩ ↩2 ↩3 ↩4

  10. Kochetova et al. 2022, https://romj.org/2022-0305 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  11. Kochetova et al. 2019, https://link.springer.com/article/10.1007/s11033-018-4544-6 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  12. Central Yakutia rural metabolic syndrome study, https://www.mediasphera.ru/issues/profilakticheskaya-meditsina/2025/5/1230549482025051021 ↩ ↩2 ↩3

  13. Sofronova et al., Metabolic Syndrome in Indigenous Minorities of the North of Yakutia, https://www.ijbm.org/articles/IJBM_8(3)_OA13.pdf ↩ ↩2

Graph View

Backlinks